Circular RNAs as Potential Biomarkers in Cancer Diagnosis and Prognosis
Circular RNAs (circRNAs) are dysregulated in cancer and may serve as biomarkers for diagnosis and prognosis.
Phase III
cancer treatment centers
Status
Active
Sponsor
clinical laboratories
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The emerging role of circular RNAs (circRNAs) as potential biomarkers in cancer diagnosis and prognosis represents a significant shift in oncology research. Pharma companies should stay informed about developments in this area to leverage new diagnostic and therapeutic opportunities.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor ongoing research and clinical trials investigating circRNAs in cancer diagnostics and therapeutic applications.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.